Patrick Soon-Shiong: NantKwest is starting down the path to conquering cancer

John Carroll

Soon-Shiong made several fortunes based on his understanding of and drug development, most recently in today's multibillion-dollar IPO for . And now he plans to put the IPO money to use in pursuit of a new strategy in immuno-oncology R&D–the single hottest field in the industry.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS